These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 24125187
1. The use of electrocochleography to monitor the response of Ménière's disease patients to intratympanic steroids. Martin-Sanz E, Luzardo CZ, Riesco LR, Patino TM, Sanz R. Acta Otolaryngol; 2013 Nov; 133(11):1158-64. PubMed ID: 24125187 [Abstract] [Full Text] [Related]
2. Transitory effect on endolymphatic hydrops of the intratympanic steroids for Ménière's disease. Martin-Sanz E, Esteban-Sanchez J, Rodrigañez-Riesco L, Sanz-Fernández R. Laryngoscope; 2015 May; 125(5):1183-8. PubMed ID: 25429741 [Abstract] [Full Text] [Related]
3. Control of vertigo after intratympanic corticoid therapy for unilateral Ménière's disease: a comparison of weekly versus daily fixed protocols. Martin Sanz E, Zschaeck C, Gonzalez M, Mato T, Rodrigañez L, Barona R, Sanz R. Otol Neurotol; 2013 Oct; 34(8):1429-33. PubMed ID: 23722456 [Abstract] [Full Text] [Related]
4. Results of electrocochleography in Ménière's disease after successful vertigo control by single intratympanic gentamicin injection. Büki B, Platz M, Haslwanter T, Jünger H, Avan P. Audiol Neurootol; 2011 Oct; 16(1):49-54. PubMed ID: 20523039 [Abstract] [Full Text] [Related]
5. Summating potential and action potential ratio in Meniere's disease before and after treatment. Orchik DJ, Shea JJ, Ge NN. Am J Otol; 1998 Jul; 19(4):478-82; discussion 483. PubMed ID: 9661758 [Abstract] [Full Text] [Related]
6. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Garduño-Anaya MA, Couthino De Toledo H, Hinojosa-González R, Pane-Pianese C, Ríos-Castañeda LC. Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029 [Abstract] [Full Text] [Related]
7. Electrocochleography and gentamicin therapy for Ménière's disease: a preliminary report. Adamonis J, Stanton SG, Cashman MZ, Mattan K, Nedzelski JM, Chen JM. Am J Otol; 2000 Jul; 21(4):534-42. PubMed ID: 10912700 [Abstract] [Full Text] [Related]
8. Intratympanic gentamicin for intractable Meniere's disease. Perez N, Martín E, García-Tapia R. Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197 [Abstract] [Full Text] [Related]
10. Treatment of Ménière's disease with "on-demand" intratympanic gentamicin injections. Manrique-Huarte R, Guillén-Grima F, Perez-Fernandez N. Otol Neurotol; 2011 Apr; 32(3):461-5. PubMed ID: 21317673 [Abstract] [Full Text] [Related]
11. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Wu IC, Minor LB. Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316 [Abstract] [Full Text] [Related]
12. Control of vertigo in Ménière's disease by intratympanic dexamethasone. Weckel A, Marx M, Esteve-Fraysse MJ. Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Feb; 135(1):7-10. PubMed ID: 28760618 [Abstract] [Full Text] [Related]
13. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease. Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T. Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414 [Abstract] [Full Text] [Related]
14. [Extratympanic electrocochleography in Ménière's disease]. Martín-Sanz E, Esteban Sánchez J, González Juliao M, Zschaeck Luzardo C, Mato Patino T, Rodrigañez Riesco L, Sanz Fernández R. Acta Otorrinolaringol Esp; 2012 Sep; 63(6):421-8. PubMed ID: 22682654 [Abstract] [Full Text] [Related]
15. The effect of intratympanic methylprednisolone and gentamicin injection on Ménière's disease. Gabra N, Saliba I. Otolaryngol Head Neck Surg; 2013 Apr; 148(4):642-7. PubMed ID: 23314159 [Abstract] [Full Text] [Related]
16. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease. Perez N, Boleas MS, Martin E. Audiol Neurootol; 2005 Apr; 10(2):69-78. PubMed ID: 15650298 [Abstract] [Full Text] [Related]
17. Response Over Time of Vertigo Spells to Intratympanic Dexamethasone Treatment in Meniere's Disease Patients. Atrache Al Attrache N, Krstulovic C, Pérez Guillen V, Morera Pérez C, Pérez Garrigues H. J Int Adv Otol; 2016 Apr; 12(1):92-7. PubMed ID: 27340991 [Abstract] [Full Text] [Related]
18. A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral Ménière's disease. Lambert PR, Nguyen S, Maxwell KS, Tucci DL, Lustig LR, Fletcher M, Bear M, Lebel C. Otol Neurotol; 2012 Sep; 33(7):1257-65. PubMed ID: 22858715 [Abstract] [Full Text] [Related]
19. A comparison of three methods of using transtympanic electrocochleography for the diagnosis of Meniere's disease: click summating potential measurements, tone burst summating potential amplitude measurements, and biasing of the summating potential using a low frequency tone. Iseli C, Gibson W. Acta Otolaryngol; 2010 Sep; 130(1):95-101. PubMed ID: 19396716 [Abstract] [Full Text] [Related]
20. Intratympanic steroids injection is effective for the treatment of drop attacks with Ménière's disease and delayed endolymphatic hydrops: A retrospective study. Liu B, Leng Y, Zhou R, Liu J, Liu D, Zhang SL, Kong WJ. Medicine (Baltimore); 2016 Dec; 95(52):e5767. PubMed ID: 28033296 [Abstract] [Full Text] [Related] Page: [Next] [New Search]